Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from Virios rapeutics

12 Health Care Stocks Moving In Tuesday's Intraday Session

Benzinga · Sep 20, 2022

Benzinga's Top Ratings Upgrades, Downgrades For September 20, 2022

Upgrades

Benzinga · Sep 20, 2022

12 Health Care Stocks Moving In Monday's Intraday Session

Benzinga · Sep 19, 2022

From analysis to the latest developments in health,
read the most diverse news in one place.

Virios Therapeutics: Q1 Earnings Insights

Virios Therapeutics (NASDAQ:VIRI) reported its Q1 earnings results on Thursday, May 12, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Benzinga · May 12, 2022

Preview: Virios Therapeutics's Earnings

Virios Therapeutics (NASDAQ:VIRI) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's what investors need to know before the announcement. Analysts estimate that Virios Therapeutics will report an earnings per share (EPS) of $-0.53.

Benzinga · May 11, 2022

A Preview Of Virios Therapeutics's Earnings

Virios Therapeutics (NASDAQ:VIRI) is set to give its latest quarterly earnings report on Thursday, 2022-03-17. Here's what investors need to know before the announcement. Analysts estimate that Virios Therapeutics will report an earnings per share (EPS) of $-0.67.

Benzinga · Mar 16, 2022

A Fireside Chat with Greg Duncan - CEO of Virios Therapeutics

NASDAQ:VIRI

Benzinga · Feb 1, 2022

Read news from The Economist, FT, and more,
with one subscription

Coverage From

Benzinga

Organisations

Norwegian Cruise Line

Martin Marietta Materials

31 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Topics

Oncology

333 stories

Read news from The Economist, FT, and more,
with one subscription

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.